Hyperthermia Cancer Treatment Market (By Device Type: Infrared Hyperthermia Devices, Ultrasound Hyperthermia Devices, Microwave Hyperthermia Devices, Others; By Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, Others; By Treatment Method; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Published Date : Jul 2021 | No. of Pages : 150+ Pages | Category : Healthcare

The global hyperthermia cancer treatment market size is expected to reach US$265 million by 2030 from US$ 160 millionin 2020, growing at a CAGR of 5.8% from 2021 to 2030. 

Hyperthermia is a form of therapy where heat is used to enhance effectiveness of radiation and chemotherapy, and to destroy tumors. Hyperthermia is most often used to treat tumors that are close to the surface of the body. In the hyperthermia treatment, the tumor area is heated to a temperature of 40 degree Celsius to 43 degree Celsius (104 degree Fahrenheit to 109 degree Fahrenheit) for approximately one hour.

Recently, several clinical trials showed that hyperthermia with radiation therapy and/or chemotherapy for the treatment of recurrent breast cancer, melanoma, head & neck cancer, prostate, cervix, and other sites of locally advanced or recurrent cancers provides additional benefits with lower side effects to destroy cancer cells.

Different types of devices used for hyperthermia treatment includes infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others.

The global hyperthermia cancer treatment market has experienced significant growth in the last decade due to rise in prevalence of various types of cancer and favorable policies.

Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment. According to the National Cancer Institute (NIH), an estimated 1,806,590 cases are expected to be diagnosed in the U.S. in 2020, with prostate, lung, and colorectal cancer likely to account for 43% of the total cancer cases in men. More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America, and 70% of the total cancer deaths globally occur in these regions.

Increase in the geriatric population directly affects the global hyperthermia cancer treatment market. The population aged 65 years and above has higher cancer incidence and mortality rate than younger people. Around 60% of cancer conditions occur among the geriatric population, 10 to 11 times higher than in the younger population.

Deep Tissue Thermal Therapy Holds Promising Potentials in Breast Cancer Treatment

The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), U.S., is gaining recognition for its comprehensive and individualized thermal therapy works. This indicates that med-tech companies are unlocking growth opportunities in the U.S., since North America is anticipated to dictate the highest revenue share among all regions in the market. The deep tissue therapy is being combined with the proton therapy to improve medical outcomes.

Ultrasound Hyperthermia Devices Provide Quality Assurance for Treatment of Cancer Patients

The therapeutic application of heat is found to be effective in cancer treatment. Hence, med-tech companies in the hyperthermia cancer treatment market are increasing their production capacities in high quality heating equipment to enable precise thermal dosimetry. This has led to innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.

High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies in the hyperthermia cancer treatment market. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.

Report Highlights

In terms of device type, the microwave hyperthermia devices segment is anticipated to grow at a rapid pace during the forecast period, as microwave technique enables heat treatment of tumors, which are deep-seated and/or relatively hard to access in the body. Hence, the preference is high among doctors. This drives the demand for microwave hyperthermia devices in cancer treatment.

Based on treatment method, the locoregional segment held a major share of the global market in 2020, owing to rise in adoption of locoregional method in the treatment of cancer associated with body cavity, organ, or limb, and increase in incidence of lung and prostate cancers.

In terms of application, the increase in incidence of breast cancer is expected to drive the segment during the forecast period. According to the World Health Organization, breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. Over 2 million new cases of breast cancer were diagnosed globally in 2018.

Based on end user, the hospitals & specialty clinics segment dominated the global hyperthermia cancer treatment market in terms of revenue in 2020.

North America dominated the global market in 2020, followed by Europe. North America accounted for a major share of the global hyperthermia cancer treatment market in 2020, attributed to increase in incidence of diseases and new product launches. 

The rise in incidence of cancers such as breast and liver and a highly structured healthcare industry fuel the growth of the market in Asia Pacific. According to the World Health Organization, 4,285,033 new cancer cases were diagnosed in China in 2018, with 2,865,174 cancer deaths.

Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.

The analysts have provided a comprehensive analysis of the competitive landscape of the global hyperthermia cancer treatment market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Key players in the global hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l., Yamamoto Vinita Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., innoMedicus Ltd., Gamida, and RanD.

Market Segmentation

By Device Type

    • Infrared Hyperthermia Devices
    • Ultrasound Hyperthermia Devices
    • Microwave Hyperthermia Devices
    • Others

By Treatment Method

    • Locoregional
      • External & Interstitial
      • Intraluminal or Endocavitary Methods
      • Continuous Hyperthermic Peritoneal Perfusion (CHPP)
      • Deep Tissue & Regional Perfusion
    • Whole-body

By Application

    • Breast Cancer
    • Liver Cancer
    • Soft Tissue Sarcoma
    • Head & Neck Tumors
    • Prostate Cancer
    • Others
    • Cancer

By End User

    • Hospitals & Specialty Clinics
    • Ambulatory Surgical Centers
    • Others

By Region

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific          
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

This report focuses on hyperthermia cancer treatment market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall hyperthermia cancer treatment market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global hyperthermia cancer treatment market.

The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.

In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global hyperthermia cancer treatment market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the hyperthermia cancer treatment market.

The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.

In this study, the years considered to estimate the market size of hyperthermia cancer treatment are as follows:

  • History Year: 2017-2019
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Research Methodology

The research methodology adopted by analysts for compiling the global hyperthermia cancer treatment market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global hyperthermia cancer treatment market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Featured Research Reports

  • Featured Research Reports

    Clinical Trial Equipment & Ancillary Solutions Market (By Product: Sourcing, Supply/Logistics, Service, Others; By Phase: Phase I, Phase II, Phase III, Phase IV) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Dental Suction Systems Market (By Product: Wet Suction, Dry Suction; By End-use: Hospitals, Dental Offices) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Dental Caries Detectors Market (By Product: Laser Fluorescent Caries Detector, Fiber Optic Trans-illumination Caries Detector; By End-use: Hospitals, Dental Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Ophthalmic Perimeters Market (By Product: Static, Kinetic, Combination; By End-use: Hospital, Ophthalmic Clinic, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Investigational New Drug CDMO Market (By Product: Small Molecule, Large Molecule; By Service: Contract Development, Contract Manufacturing; By End-use: Pharmaceutical Companies, Biotech Companies, Others (Government, Research Institutes, Academic Institutes, etc.)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...